Cancer News and Research

Latest Cancer News and Research

Investing in personalized medicine will benefit Canada

Canada has the opportunity to be an international leader in personalized medicine and needs to invest in this area for the health of Canadians and to reap the benefits of job creation, writes Dr. Thomas Hudson in a commentary http://www.cmaj.ca/cgi/rapidpdf/cmaj.1090199 released online today in CMAJ ( Canadian Medical Association Journal ).

20 Feb 2009

Human papillomavirus lesion identified with VELscope at dentist

Human papillomavirus (HPV) is a group of viruses that includes more than 100 different strains or types and is the most common sexually transmitted virus.

20 Feb 2009

Racial disparities in colorectal cancer screening persist

Colorectal cancer screening among patients with Medicare coverage is increasing, but a persistent gap remains between whites - who are screened most frequently - and all other racial and ethnic groups, according to a new study by researchers at UC Davis and the University of Washington.

20 Feb 2009

Cancer Research UK launches first super cancer centre in Birmingham

Birmingham will become the first link in a unique chain of Cancer Research UK Centres to be launched round the country.

20 Feb 2009

Cancer death rates fall among African Americans - survival rates still low

While death rates from cancer continue to drop among African Americans, the group continues to be diagnosed at more advanced stages and have lower survival rates at each stage of diagnosis compared to whites for most cancer sites.

20 Feb 2009

Blood pressure drug losartan may benefit brain tumor patients

A widely used blood pressure medication may be the key to preventing brain function loss common after radiation treatment, according to a newly published study by researchers at Wake Forest University Baptist Medical Center.

20 Feb 2009

Mutations in two genes linked to most common brain cancers

Scientists at the Johns Hopkins Kimmel Cancer Center and Duke University Medical Center have linked mutations in two genes, IDH1 and IDH2, to nearly three-quarters of several of the most common types of brain cancers known as gliomas.

20 Feb 2009

Tumor suppressor may weaken fibrotic disease

New research reveals a critical cellular signaling pathway that is responsible for generating excess connective tissue in multiple organs, similar to what is seen in human patients with scleroderma.

18 Feb 2009

Nano-sized laboratory detects pollutants, disease and biological weapons

For centuries, animals have been our first line of defense against toxins.

18 Feb 2009

Cancer survivors more likely to be unemployed

An analysis of previous studies finds an association between being a cancer survivor and being unemployed, compared to healthy individuals, especially for survivors of breast and gastrointestinal cancers, according to an article in the February 18 issue of JAMA, the Journal of the American Medical Association.

18 Feb 2009

Handheld device provides on-the-spot DNA analysis to test tolerance to prescription drugs

A handheld device to predict whether patients will respond adversely to medication is one step closer to the market, thanks to a new partnership.

18 Feb 2009

One-quarter of California adolescent girls has had HPV vaccine

Less than two years after the HPV vaccine was approved as a routine vaccination for girls aged 11 and older, one-quarter of California adolescent girls have started the series of shots that protect against human papillomavirus, which is strongly linked to cervical cancer.

18 Feb 2009

Opportunities for the health system in a sick economy

With the interim report of the National Health and Hospitals Reform Commission published yesterday the time for implementing reform could hardly be better.

18 Feb 2009

Genetic ID of marker in lymph nodes may be linked to colorectal cancer recurrence risk

A preliminary report suggests that genetic testing may help identify a marker in lymph nodes that is associated with an increased risk of colorectal cancer recurrence among patients in whom conventional testing indicates that those lymph nodes show no evidence of cancer spread, according to a study in the February 18 issue of JAMA.

18 Feb 2009

GABAergic system shows promise as molecular target for liver cancer therapy

Although GABA and GABA receptors function as an inhibitory neurotransmitter in the mature CNS, abnormal levels of gene and protein expression of some GABA receptor subunits have been detected in many malignant tumors, such as ð subunit in pancreatic cancer.

18 Feb 2009

Experts predict 20 per cent drop in lung cancer rate

Cancer Reserach UK experts are predicting that lung cancer rates will drop by nearly a fifth over the next 20 years, according to new figures.

18 Feb 2009

Presence of a biomarker in regional lymph nodes predicts disease recurrence in colorectal cancer

Findings published in the Journal of the American Medical Association by researchers at Thomas Jefferson University show that the presence of a biomarker in regional lymph nodes is an independent predictor of disease recurrence in patients with colorectal cancer.

18 Feb 2009

An adjuvant chemotherapeutic agent in gastric cancer therapy

Peritoneal carcinomatosis can be thought of as a series of events that together form a peritoneal metastatic cascade.

18 Feb 2009

Newly discovered mutation can hold the key to treat a large number of different cancers

Scientists have discovered a mutation responsible for cancer progression, a finding with potential implications for the development of treatment against not one, but a series of cancer types since this mutation can be linked to an abnormality recently discovered to exist in all malignancies.

18 Feb 2009